Overview

A Clinical Study of MK-1084 in Participants With Renal Impairment (MK-1084-010)

Status:
RECRUITING
Trial end date:
2025-11-21
Target enrollment:
Participant gender:
Summary
The goal of this study is to learn what happens to MK-1084 levels in a person's body over time. Researchers will measure what happens to MK-1084 levels in the body when it is given to people with moderate or severe renal impairment (RI) (meaning the kidneys do not work properly) as compared to people who are in good health. Researchers also want to learn about the safety of MK-1084 when it is given to people with RI and if people with RI can tolerate it.
Phase:
PHASE1
Details
Lead Sponsor:
Merck Sharp & Dohme LLC